Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

5.67
Delayed Data
As of May 27
 +0.08 / +1.43%
Today’s Change
3.55
Today|||52-Week Range
23.39
-45.38%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close5.59
Today’s open5.63
Day’s range5.49 - 5.75
Volume74,051
Average volume (3 months)207,230
Market cap$195.3M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio115.9
Price/Sales9.15
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...-0.41-2.76%
ENZYEnzymotec Ltd+0.01+0.11%
CYTRCytRx Corp+0.03+1.09%
EVGNEvogene Ltd+0.01+0.15%
Data as of 4:01pm ET, 05/27/2016

Financials

Last reporting dateMay 30, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers

Search for Jobs